Found 5 results

Name Type of Offering Accepted Date
Alcresta Therapeutics, Inc. See All Filings
D/A 2016-10-31 16:43:21
Amount To Be Raised $50,889,675
Associated Brokers / Dealers N/A
CIK Number 0001673510
Filed Document 0001140361-16-084182
Exclusions or Exemptions 506b
Accepted Date 2016-10-31 16:43:21
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Alcresta Therapeutics, Inc. See All Filings
D 2017-09-25 14:42:43
Amount To Be Raised $34,999,978
Associated Brokers / Dealers N/A
CIK Number 0001673510
Filed Document 0001673510-17-000002
Exclusions or Exemptions 506b
Accepted Date 2017-09-25 14:42:43
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW JERSEY
Revenue or Assets Decline to Disclose
Type of Security Equity
Alcresta, Inc. See All Filings
D 2016-06-14 15:56:31
Amount To Be Raised $49,389,680
Associated Brokers / Dealers N/A
CIK Number 0001673510
Filed Document 0001140361-16-069707
Exclusions or Exemptions 506b
Accepted Date 2016-06-14 15:56:31
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Alcresta Therapeutics, Inc. See All Filings
D 2020-03-03 13:46:00
Amount To Be Raised $19,999,998
Associated Brokers / Dealers N/A
CIK Number 0001673510
Filed Document 0001673510-20-000001
Exclusions or Exemptions 506b
Accepted Date 2020-03-03 13:46:00
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW JERSEY
Revenue or Assets Decline to Disclose
Type of Security Equity
Alcresta Therapeutics, Inc. See All Filings
D 2019-01-23 10:51:16
Amount To Be Raised $25,000,000
Associated Brokers / Dealers N/A
CIK Number 0001673510
Filed Document 0001673510-19-000001
Exclusions or Exemptions 506b
Accepted Date 2019-01-23 10:51:16
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW JERSEY
Revenue or Assets Decline to Disclose
Type of Security Equity